- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02241733
Sustainability of Pulmonary Rehab Gains
Sustainability of Rehabilitation Gains in COPD
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Rationale: Development of dynamic hyperinflation is a primary limiting factor of exercise tolerance in chronic obstructive pulmonary disease (COPD). To lessen the development of dynamic hyperinflation, and to improve exercise tolerance in COPD patients, the investigators have developed a breathing-retraining technique to be used during pulmonary rehabilitation. This breathing-retraining technique is designed to decrease respiratory rate and prolong exhalation. The investigators demonstrated that, in the short-term, hyperinflation and exercise duration improved more with breathing-retraining plus exercise-training than with exercise-training alone. Because a crucial aspect of pulmonary rehabilitation is the maintenance its short-term benefits over the long-term, the investigators now propose to test whether short-term benefits of breathing-retraining plus exercise followed by an adherence-intervention program are sustainable over the long-term Primary Hypothesis: (H1) In COPD patients, improvements in exercise duration on a constant- load treadmill test will be greater after 12 weeks of breathing-retraining plus exercise-training followed by a 42-week adherence-intervention program (1 yr. total) than after 12 weeks of exercise-training alone followed by a 42-week adherence-intervention program (1 yr. total). Secondary Hypotheses: One year after randomization, exercise-induced dynamic hyperinflation will be less during a constant-load treadmill test (H2), 6-minute walking distance will be longer (H3), and mastery over breathing will be greater (H4) in the breathing-retraining plus exercise-training group than in the exercise-alone group. Lastly (exploratory objective), the investigators will assess the effect of the patient's physiologic, psychologic and clinical phenotype on short- term and long-term responsiveness to pulmonary rehabilitation.
Methods: The proposed study is a randomized, controlled clinical trial in which 250 patients with moderate-to-severe COPD will be enrolled. One hundred forty of these patients are expected to qualify for randomization into the breathing-retraining plus exercise-training group or the exercise-training alone group. Patients will receive 12-weeks of supervised training according to group assignment (three times weekly) followed by an adherence-intervention program (weekly phone motivational interviews, home-exercise program, and monthly laboratory booster sessions). Follow-up testing will be completed at 12 weeks, and at 6 and 12 months. Testing will include pulmonary function test, incremental-load and constant-load treadmill tests, 6-minute walk test, measurements of dyspnea, assessment of respiratory and quadriceps muscle strength and endurance and quadriceps ultrasonography. Analysis: In the principal analysis of the primary outcome measure (exercise duration; H1) the investigators will compare changes in exercise duration (constant work-rate treadmill test) from baseline to end of study using 2-sample t-test (two-tailed =.05). The primary analysis will be based on intention-to-treat principles. Multiple imputation will be used for study subjects missing the 12-month measurement. This imputation model will be based on baseline characteristics of study participants. Several secondary analyses of the primary outcome measure will be performed (H2-H4). Linear regression will be used to determine whether the observed treatment benefits persist after adjustment for baseline covariates and measures of adherence to treatment. Since several measurements will be taken on each patient, mixed-models analysis will be used to compare the changes on the constant-load treadmill test over time between the two groups.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Illinois
-
Hines, Illinois, Forenede Stater, 60141-5000
- Edward Hines Jr. VA Hospital, Hines, IL
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- >/= 40 yrs
- FEV1 </= 70% predicted
- FEV1/FVC <70% predicted
- RV/TLC >/=120%
- SpO2 >/= 90% at peak exercise (with or without exercise)
- inspiratory capacity decline >.15L from rest to peak exercise
Exclusion Criteria:
- respiratory infection/exacerbation within the previous 4 weeks
- exercise limiting heart disease
- primary asthma
- congestive heart failure
- exercise limiting peripheral arterial disease
- stops exercise due to arthritic pain in the knee or hips
- inability to walk on the treadmill
- pregnancy
- methadone use
- any unforeseen illness or disability that would preclude exercise testing or training
- participation in a formal exercise program within the previous 12 weeks
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Faktoriel opgave
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: exercise
Patients will exercise for 12 weeks and then participate in an adherence program
|
Patients will participate in a 12-week exercise program .
They will also participate in an adherence program.
|
Eksperimentel: exercise plus breathing retraining
Patients will exercise plus breathing retraining for 12 weeks and then participate in an adherence program
|
Patients will participate in a 12-week exercise program with breathing retraining.
They will also participate in an adherence program.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Duration of Exercise Time on a Constant Work-rate Treadmill Test
Tidsramme: 52 week test
|
Patients walk on a treadmill set at a constant workrate.
The difference in the time walked on the treadmill from baseline to study completion is the primary outcome measure.
|
52 week test
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Inspiratory Capacity
Tidsramme: 52 week test
|
Inspiratory capacity is measured at a set time during the constant workrate treadmill test.
The difference between the inspiratory capacity measured at baseline and 52 weeks is a secondary outcome.
Inspiratory capacity measured during exercise is a measure of dynamic hyperinflation.
|
52 week test
|
6 Minute Walk Distance
Tidsramme: 52 weeks
|
Six-minute walk distance will be measured at 52 weeks.
The difference in distance walked in meters between baseline and 52 weeks is the secondary outcome measure.
The 6 minute walk is conducted using the guidelines issued by the American Thoracic Society.
|
52 weeks
|
Mastery Over Breathing
Tidsramme: 52 weeks
|
Mastery over breathing is measured using the Chronic Respiratory Disease Questionnaire.
Specifically the subscale 'mastery" is the investigators' secondary outcome.
The difference in scores from baseline to 52 weeks is the investigators' outcome measure.
The Chronic Respiratory Disease Questionnaire is a valid and reliable questionnaire.
1=minimum score, 7=maximum with the higher score indicating greater mastery.
A higher score indicates better health.
A change of 0.5 indicates a small change, 1.0 indicates a moderate change and greater or equal to a change of 1.5 indicates a large change.
|
52 weeks
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Eileen G. Collins, PhD RN, Edward Hines Jr. VA Hospital, Hines, IL
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- O1325-R
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med KOL
-
Baylor Research InstituteIkke rekrutterer endnu
-
Vastra Gotaland RegionRekruttering
-
Baystate Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); University of Illinois... og andre samarbejdspartnereTrukket tilbage
-
Centre Hospitalier Intercommunal CreteilUniversity Hospital, Bordeaux; University Hospital, Caen; Centre Hospitalier... og andre samarbejdspartnereUkendt
-
Assiut UniversityIkke rekrutterer endnu
-
University of CalgaryAktiv, ikke rekrutterende
-
Marmara UniversityAfsluttet
-
University Hospital, BrestAfsluttet
-
VA Boston Healthcare SystemUkendt
-
Assiut UniversityIkke rekrutterer endnu
Kliniske forsøg med Exercise only
-
University of CoimbraFundação para a Ciência e a TecnologiaUkendt
-
Beth Israel Deaconess Medical CenterNational Institute on Aging (NIA); Hebrew SeniorLifeRekrutteringÅndedrætssvigt | Aldring | Koma | Enden på livet | VentilationssvigtForenede Stater
-
Ospedale San RaffaeleIstituto Clinico Humanitas; Central Clinical Hospital of the Ministry of...RekrutteringMitral regurgitation | Trikuspidal sygdomItalien, Polen
-
Medtronic Cardiac Rhythm and Heart FailureAfsluttet
-
National Institute of Cardiology, Warsaw, PolandRekrutteringKoronararteriesygdom | Total okklusion af koronararterieSpanien, Frankrig, Ungarn, Tjekkiet, Polen, Østrig, Kroatien, Tyskland, Israel, Italien, Rumænien
-
University of PisaAzienda Ospedaliero, Universitaria Pisana; Azienda Ospedaliero-Universitaria... og andre samarbejdspartnereTilmelding efter invitationHjerneskader | For tidlig fødselItalien
-
Penn State UniversityIkke rekrutterer endnuAlzheimers sygdom og relaterede demenssygdommeForenede Stater
-
Savvysherpa, Inc.AfsluttetType 2 diabetesForenede Stater
-
Savvysherpa, Inc.AfsluttetType 2 diabetesForenede Stater
-
GlaxoSmithKlineAfsluttetSmerteForenede Stater